BNF 74 : September 2017 - March 2018.
Material type:
TextPublisher: London : BMJ Group : Pharmaceutical Press, [2017]Description: xx, 1529 pages : illustrations (some color) ; 21 cmContent type: - text
- unmediated
- volume
- 9780857112989
- 0857112988
- British national formulary : book 74
- British Medical Association [associated name.]
- Royal Pharmaceutical Society of Great Britain [associated name.]
- 615.1341 B 23
- RS141.3 B54 2017
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 1 | Not For Loan | 00013416 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 2 | Not For Loan | 00013417 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 3 | Not For Loan | 00013418 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 4 | Not For Loan | 00013419 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 5 | Not For Loan | 00013420 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 6 | Not For Loan | 00013421 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 7 | Not For Loan | 00013422 | ||
|
Reference
|
Main library C2 REF | Pharmacy ( Pharmaceutical Technology ) | 615.1341 B (Browse shelf(Opens below)) | 8 | Not For Loan | 00013429 |
Browsing Main library shelves, Shelving location: C2 REF Close shelf browser (Hides shelf browser)
Includes index.
"Published under the authority of a Joint Formulary Committee"--Preface.
This biannual publication provides details on all medicines currently available on the UK market, with particular reference to their uses, contraindications, side effects, dosage and relative cost.
There are no comments on this title.